Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2025
|
| Schlagworte: | |
| Online-Zugang: | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6485 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867017810539970560 |
|---|---|
| author | Naoki Yamamoto Norihiko Sakai Yuta Yamamura Daichi Kaikoi Daiki Hayashi Takahiro Matsuno Akihiko Koshino Keisuke Sako Keisuke Horikoshi Takahiro Yuasa Akira Tamai Taichiro Minami Megumi Oshima Shiori Nakagawa Shinji Kitajima Akinori Hara Miho Shimizu Jumpei Terakawa Shin‐ichi Horike Takiko Daikoku Atsushi Mizokami Hiroko Ikeda Moeno Kadoguchi Hiroshi Arakawa Sumio Ohtsuki David Lagares Takashi Wada Yasunori Iwata |
| author_facet | Naoki Yamamoto Norihiko Sakai Yuta Yamamura Daichi Kaikoi Daiki Hayashi Takahiro Matsuno Akihiko Koshino Keisuke Sako Keisuke Horikoshi Takahiro Yuasa Akira Tamai Taichiro Minami Megumi Oshima Shiori Nakagawa Shinji Kitajima Akinori Hara Miho Shimizu Jumpei Terakawa Shin‐ichi Horike Takiko Daikoku Atsushi Mizokami Hiroko Ikeda Moeno Kadoguchi Hiroshi Arakawa Sumio Ohtsuki David Lagares Takashi Wada Yasunori Iwata Naoki Yamamoto Norihiko Sakai Yuta Yamamura Daichi Kaikoi Daiki Hayashi Takahiro Matsuno Akihiko Koshino Keisuke Sako Keisuke Horikoshi Takahiro Yuasa Akira Tamai Taichiro Minami Megumi Oshima Shiori Nakagawa Shinji Kitajima Akinori Hara Miho Shimizu Jumpei Terakawa Shin‐ichi Horike Takiko Daikoku Atsushi Mizokami Hiroko Ikeda Moeno Kadoguchi Hiroshi Arakawa Sumio Ohtsuki David Lagares Takashi Wada Yasunori Iwata |
| collection | Wiley Open Access |
| contents | Fibroblast‐specific palladin drives kidney fibrosis via MRTF – SRF signaling Naoki Yamamoto Norihiko Sakai Yuta Yamamura Daichi Kaikoi Daiki Hayashi Takahiro Matsuno Akihiko Koshino Keisuke Sako Keisuke Horikoshi Takahiro Yuasa Akira Tamai Taichiro Minami Megumi Oshima Shiori Nakagawa Shinji Kitajima Akinori Hara Miho Shimizu Jumpei Terakawa Shin‐ichi Horike Takiko Daikoku Atsushi Mizokami Hiroko Ikeda Moeno Kadoguchi Hiroshi Arakawa Sumio Ohtsuki David Lagares Takashi Wada Yasunori Iwata The Journal of Pathology Abstract Fibrosis is a common end‐stage pathway of progressive chronic kidney diseases. Previously we demonstrated that myocardin‐related transcription factor (MRTF)–serum response factor (SRF) signaling drives the expression of fibrosis‐related molecules through actin cytoskeleton dynamics in renal fibroblasts. However, it has not been elucidated whether actin‐associated proteins relate to the pathogenesis of fibrosis. Here, we reveal that the actin cytoskeleton‐regulating pathway is significantly correlated with estimated glomerular filtration rate (eGFR) and collagen type 1 alpha 1 expression in human proteome analysis. We found that palladin was one of the TGF‐β1‐dependent actin‐associated proteins in renal fibroblasts. Our mechanistic studies demonstrated that palladin activates MRTF–SRF signaling via actin cytoskeleton rearrangement upon TGF‐β1 stimulation. In addition, palladin expression itself was enhanced by MRTF–SRF signaling, indicating a positive feedback loop. In vitro , genetic silencing of the palladin–MRTF–SRF axis suppressed extracellular matrix production and myofibroblast differentiation. In preclinical models in vivo , fibroblast‐specific palladin‐deficient mice (palladin iFBKO ) were protected from kidney dysfunction and fibrosis that developed in adenine‐induced nephropathy, which was associated with reduced numbers of myofibroblasts compared to wild type (palladin F/F ) mice. In patients with renal disease, palladin was significantly upregulated in the renal interstitium of patients with low eGFR and kidney fibrosis. Moreover, upregulation of the palladin–MRTF–SRF axis correlated with kidney function and fibrosis in patients with various kidney diseases, including IgA nephropathy, diabetic nephropathy, and nephrosclerosis. Taken together, we consider palladin to be a novel regulator of actin cytoskeleton signaling in fibrotic fibroblasts and represents a novel therapeutic target for the treatment of progressive kidney diseases. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6485 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/path.6485 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_6485 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Fibroblast‐specific palladin drives kidney fibrosis via MRTF – SRF signaling Naoki Yamamoto Norihiko Sakai Yuta Yamamura Daichi Kaikoi Daiki Hayashi Takahiro Matsuno Akihiko Koshino Keisuke Sako Keisuke Horikoshi Takahiro Yuasa Akira Tamai Taichiro Minami Megumi Oshima Shiori Nakagawa Shinji Kitajima Akinori Hara Miho Shimizu Jumpei Terakawa Shin‐ichi Horike Takiko Daikoku Atsushi Mizokami Hiroko Ikeda Moeno Kadoguchi Hiroshi Arakawa Sumio Ohtsuki David Lagares Takashi Wada Yasunori Iwata The Journal of Pathology Fibroblast‐specific palladin drives kidney fibrosis via MRTF – SRF signaling Naoki Yamamoto Norihiko Sakai Yuta Yamamura Daichi Kaikoi Daiki Hayashi Takahiro Matsuno Akihiko Koshino Keisuke Sako Keisuke Horikoshi Takahiro Yuasa Akira Tamai Taichiro Minami Megumi Oshima Shiori Nakagawa Shinji Kitajima Akinori Hara Miho Shimizu Jumpei Terakawa Shin‐ichi Horike Takiko Daikoku Atsushi Mizokami Hiroko Ikeda Moeno Kadoguchi Hiroshi Arakawa Sumio Ohtsuki David Lagares Takashi Wada Yasunori Iwata The Journal of Pathology Abstract Fibrosis is a common end‐stage pathway of progressive chronic kidney diseases. Previously we demonstrated that myocardin‐related transcription factor (MRTF)–serum response factor (SRF) signaling drives the expression of fibrosis‐related molecules through actin cytoskeleton dynamics in renal fibroblasts. However, it has not been elucidated whether actin‐associated proteins relate to the pathogenesis of fibrosis. Here, we reveal that the actin cytoskeleton‐regulating pathway is significantly correlated with estimated glomerular filtration rate (eGFR) and collagen type 1 alpha 1 expression in human proteome analysis. We found that palladin was one of the TGF‐β1‐dependent actin‐associated proteins in renal fibroblasts. Our mechanistic studies demonstrated that palladin activates MRTF–SRF signaling via actin cytoskeleton rearrangement upon TGF‐β1 stimulation. In addition, palladin expression itself was enhanced by MRTF–SRF signaling, indicating a positive feedback loop. In vitro , genetic silencing of the palladin–MRTF–SRF axis suppressed extracellular matrix production and myofibroblast differentiation. In preclinical models in vivo , fibroblast‐specific palladin‐deficient mice (palladin iFBKO ) were protected from kidney dysfunction and fibrosis that developed in adenine‐induced nephropathy, which was associated with reduced numbers of myofibroblasts compared to wild type (palladin F/F ) mice. In patients with renal disease, palladin was significantly upregulated in the renal interstitium of patients with low eGFR and kidney fibrosis. Moreover, upregulation of the palladin–MRTF–SRF axis correlated with kidney function and fibrosis in patients with various kidney diseases, including IgA nephropathy, diabetic nephropathy, and nephrosclerosis. Taken together, we consider palladin to be a novel regulator of actin cytoskeleton signaling in fibrotic fibroblasts and represents a novel therapeutic target for the treatment of progressive kidney diseases. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6485 http://creativecommons.org/licenses/by/4.0/ |
| title | Fibroblast‐specific palladin drives kidney fibrosis via MRTF – SRF signaling |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6485 |